- Home
- WSM vs HUMAW Comparison
WSM vs HUMAW Comparison
Compare WSM & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSM
- HUMAW
- Stock Information
- Founded
- WSM 1956
- HUMAW 2004
- Country
- WSM United States
- HUMAW United States
- Employees
- WSM N/A
- HUMAW 220
- Industry
- WSM Home Furnishings
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- WSM Consumer Discretionary
- HUMAW Health Care
- Exchange
- WSM Nasdaq
- HUMAW Nasdaq
- Market Cap
- WSM N/A
- HUMAW N/A
- IPO Year
- WSM N/A
- HUMAW N/A
- Fundamental
- Price
- WSM $173.78
- HUMAW $0.42
- Analyst Decision
- WSM Hold
- HUMAW
- Analyst Count
- WSM 18
- HUMAW 0
- Target Price
- WSM $170.06
- HUMAW N/A
- AVG Volume (30 Days)
- WSM 1.5M
- HUMAW 14.2K
- Earning Date
- WSM 08-21-2025
- HUMAW 03-21-2025
- Dividend Yield
- WSM 1.52%
- HUMAW N/A
- EPS Growth
- WSM 6.75
- HUMAW N/A
- EPS
- WSM 8.66
- HUMAW N/A
- Revenue
- WSM $7,781,306,000.00
- HUMAW N/A
- Revenue This Year
- WSM $1.35
- HUMAW N/A
- Revenue Next Year
- WSM $3.07
- HUMAW N/A
- P/E Ratio
- WSM $20.07
- HUMAW N/A
- Revenue Growth
- WSM 1.64
- HUMAW N/A
- 52 Week Low
- WSM $125.33
- HUMAW $1.18
- 52 Week High
- WSM $219.98
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- WSM 65.36
- HUMAW N/A
- Support Level
- WSM $165.19
- HUMAW N/A
- Resistance Level
- WSM $174.28
- HUMAW N/A
- Average True Range (ATR)
- WSM 4.72
- HUMAW 0.00
- MACD
- WSM 1.40
- HUMAW 0.00
- Stochastic Oscillator
- WSM 97.50
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.